POLYMARKET SEEKS $400M AT $15B VALUATION
AI DESK■ 1 MIN READ
MON, APR 20, 2026■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE
Prediction market platform Polymarket is in fundraising talks at a $15 billion post-money valuation, up 67% from October 2025's $9 billion valuation. The round trails competitor Kalshi's $22 billion valuation from March 2026.
Polymarket is seeking $400 million in new funding, according to sources cited by The Information. The valuation increase from $9 billion to $15 billion reflects growing investor interest in prediction markets amid regulatory shifts.
The funding round positions Polymarket as a major player in the sector, though below Kalshi's recent $22 billion valuation. Both platforms operate in the prediction market space, which has gained traction following changes in regulatory enforcement.
Polymarket operates on Polygon, a layer-2 Ethereum network, enabling users to trade contracts based on future outcomes across politics, sports, and other categories. The platform has processed billions in trading volume.
The funding reflects broader venture capital appetite for crypto-native platforms operating in traditionally regulated spaces. Kalshi, which obtained regulatory approval from the CFTC, commands a higher valuation despite operating with different market conditions.
Details on the funding round's timeline and lead investors remain unclear.
■ SOURCES
► Techmeme■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE
■ MORE FROM THE STARTUPS DESK
Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.
YESTERDAY— AI Desk
Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.
YESTERDAY— AI Desk
Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.
YESTERDAY— AI Desk
H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.
YESTERDAY— Industry Desk